Clinical Trial Update: Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 trial results for SPARC1310 in seasonal allergic rhinitis have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• SPARC1310

Snippet

Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2016-04-11